The estimated daily tumor growth, calculated by the formulation (tumor volume at day 42 − tumor volume at day 0)/42, confirmed that MAFG shRNA or miR-4660 overexpression robustly inhibited pOS-1 xenograft growth in SCID mice (Figure 8B). The gene discussed is MAFG; the disease is neoplasm.